Article
AAV-microdystrophin Therapy Improves Cardiac Performance in Aged Female mdx Mice
2 Aug 2011
Abstract excerpt
Dystrophin deficiency leads to lethal dilated Duchenne cardiomyopathy. A promising therapy is to deliver a highly abbreviated microdystrophin gene to the heart using adeno-associated virus (AAV). Microdystrophin has been shown to mitigate dystrophin-deficient skeletal muscle disease. However, it is not clear whether microdystrophin is equally effective in treating Duchenne cardiomyopathy. To evaluate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
